ASTRO 2025 Annual Meeting Press Kit
The 2025 ASTRO Annual Meeting – the leading global conference in radiation oncology – is being held at San Francisco’s Moscone Center from September 27 to October 1. Led by ASTRO President Sameer Keole, MD, FASTRO, the meeting is organized around the theme, “Rediscovering Radiation Medicine and Exploring New Indications.” More than 2,500 abstracts, presented alongside educational panels, keynote addresses and other special programming, explore the latest updates in radiation oncology, clinical trials results and patient care improvements. For additional details, view our media advisory and find schedule and presenter details in the Annual Meeting portal.
News Briefings
Monday, September 29
Briefing Studies
Primary results for the phase III trial of toxicity reduction using proton beam therapy for oropharyngeal cancer (TORPEdO; CRUK/18/010) (LBA 02), presented by David Thomson, MD (news release, briefing slides)
A double-blinded placebo-controlled biomarker stratified randomized trial of apalutamide (APA) and radiotherapy for recurrent prostate cancer (NRG GU006, BALANCE trial) (LBA 04), presented by Daniel Spratt, MD (news release, briefing slides)
Bladder Adjuvant RadioTherapy (BART): Clinical outcomes from a phase III multicenter randomized controlled trial (Abstract 2), presented by Vedang Murthy, MD (news release, briefing slides)
177Lutetium-PSMA neoadjuvant to ablative radiotherapy for oligorecurrent prostate cancer: Primary endpoint analysis of the phase II LUNAR randomized trial (Abstract 3), presented by Amar Kishan, MD, PhD (news release, briefing slides)
Clinical effectiveness of single course low-dose radiation therapy in knee osteoarthritis: Short-term results from the randomized, sham-controlled trial (LBA 06), presented by Byoung Hyuck Kim, MD, PhD (news release, briefing slides)
Expert comments from C. Jillian Tsai, MD, PhD; Chad Tang, MD; Kristina Mirabeau-Beale, MD, MPH
Moderated by Catheryn Yashar, MD, FASTRO, incoming ASTRO President-elect
Tuesday, September 30
Briefing Studies
Phase III randomized trial of proton vs. photon therapy for patients with non-metastatic breast cancer receiving comprehensive nodal radiation: A radiotherapy comparative effectiveness (RADCOMP) consortium trial: Health-related quality of life outcomes (LBA 01), presented by Shannon MacDonald, MD, FASTRO (news release, briefing slides)
Primary results from NRG-GU005: A phase III trial of SBRT vs. hypofractionated IMRT for localized intermediate risk prostate cancer (Abstract 1), presented by Rodney Ellis, MD (news release, briefing slides)
Stereotactic arrhythmia radiotherapy (STAR) vs. repeat catheter ablation for high-risk refractory ventricular tachycardia: 3-year safety and efficacy outcomes (Abstract 247), presented by Shannon Jiang, MD (news release, briefing slides)
Ten-year outcomes of the revised STARS trial comparing radiation and surgery for early-stage non-small cell lung cancer (Abstract 268), presented by Joe Chang, MD, PhD, FASTRO (news release, briefing slides)
- Expert comments from Jose Bazan, MD; Leslie Ballas, MD, FASTRO; Kenneth Rosenzweig, MD, FASTRO
Moderated by Kenneth Rosenzweig, MD, FASTRO, Chair of the ASTRO Annual Meeting Scientific Committee
Press Registration
ASTRO provides complimentary meeting registration to credentialed news professionals representing media organizations for the express purpose of gathering news and information to produce editorial coverage of the ASTRO Annual Meeting. Read more about eligibility for press registration.
ASTRO will host an on-site press office in room 104 of the Moscone Center for reporters covering the meeting in person.
Embargo Policy and Access to Abstracts
All abstracts to be presented at the ASTRO Annual Meeting are embargoed until 5:00 p.m. Eastern time on Friday, September 26, 2025. For more details, view the full embargo policy. Contact ASTRO's media relations team with questions about the embargo policy or for press access to embargoed materials.
Abstracts will be available online via the Annual Meeting Portal when the embargo lifts. Abstracts also will be published and available at that time in the International Journal of Radiation Oncology • Biology • Physics (Red Journal).
For More Information
Visit the Annual Meeting Portal (abstracts, disclosures, schedule) or ASTRO 2025 microsite (general meeting info).
View our PR Policies for Industry Partners.
Connect with us on social media.
Find patient information at RTAnswers.org.
Contact ASTRO’s media relations team.
